Transport of Aflatoxin M(1) in Human Intestinal Caco-2/TC7 Cells

Francesca Caloni1, Cristina Cortinovis, Fabiola Pizzo

  • 1Department of Health, Animal Science and Food Safety, Universitá degli Studi di Milano Milan, Italy.

Insights

Aflatoxin M1 (AFM1) is poorly absorbed by intestinal cells and does not permanently damage tight junctions, suggesting limited risk from this milk contaminant. Further research is needed to clarify its transport mechanism.

Area of Science:

  • Toxicology
  • Food Safety
  • Cell Biology

Background:

  • Aflatoxin M1 (AFM1) is a milk-borne metabolite of aflatoxin B1 (AFB1).
  • Limited and outdated literature exists on AFM1 metabolism, toxicity, and bioavailability.
  • Human exposure to AFM1 poses potential health risks.

Purpose of the Study:

  • To investigate the absorption profile of AFM1 in intestinal cells.
  • To assess the impact of AFM1 on intestinal tight junctions (TJ).
  • To evaluate the potential risk of human exposure to AFM1.

Main Methods:

  • Utilized Caco-2/TC7 cell monolayers grown on microporous filters.
  • Exposed cells to varying AFM1 concentrations for short (40 min) and long (48 h) durations.
  • Measured trans-epithelial electrical resistance and TJ protein localization (Zonula occludens-1, occludin) to assess barrier integrity and AFM1 transport.

Main Results:

  • AFM1 exhibited poor absorption by Caco-2/TC7 cells but rapid transport across the monolayer (P(app) = 105.10 × 10⁻⁶ cm/s).
  • Intestinal tight junction integrity was not permanently compromised by AFM1 exposure.
  • No significant cell viability impairment or barrier damage was observed.

Conclusions:

  • AFM1 demonstrates limited absorption and transient effects on intestinal barrier integrity.
  • Findings contribute to the human risk assessment of AFM1 exposure.
  • Further investigation is required to elucidate the AFM1 transport mechanism across intestinal cells.

Related Concept Videos

Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Transcellular Transport of Solutes01:23

Transcellular Transport of Solutes

Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...